Navigation Links
Fluidigm Due Diligence: Company SWOT Analysis and Market Opportunity 2012
Date:3/11/2013

DUBLIN, March 11, 2013 /PRNewswire/ --

Research and Markets has announced the addition of the "Fluidigm Due Diligence: Company SWOT Analysis and Market Opportunity" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

In this report, we review Fluidigm's historical financial performance, and forecast Fluidigm's product revenues (2012E-2015F) by platform (BioMark / BioMark HD, EP1, Access array, C1 single cell AutoPrep system [to be launched] and TOPAZ). Overall, we believe the company will grow at >25% p.a. until 2015 and reach revenues in excess of $100M. The majority of this growth is expected to be driven by continued placement of BioMark systems, especially for single-cell analysis. By the end of 2011, the company reported that >80 BioMark systems were being used for single-cell analysis. We expect this number to grow to 250-300 instruments by 2015.

In addition, this report provides an overview of the genomics and molecular diagnostics (MDx) spaces in which Fluidigm participates. We review the market growth and trends of both genomics and MDx by technology. The WW genomics market was estimated at -$6.8B in 2011, and forecasted to grow at -6% p.a. Fluidigm focuses on sub-segments of this market, at a specific throughput and plex-level. In addition, Fluidigm addresses three segments within this market: NGS sample preparation, single cell genomics and dPCR. We estimate the current (2011) and future (2015) market size for each of these niche segments.

We also provide an overview of the competitive landscape, with a key focus on dPCR, for which we provide a profile of 7 key competitors.

This report is based on an extensive review of Fluidigm's filings, publications and earning calls. In addition, we supplemented our analysis with an interview campaign of -18 users and non-users of various Fluidigm platforms. This information is compiled into a SWOT analysis presented at the end of the report.


Key Topics Covered:

Products and key applications

Customer types and installed base

Past and current revenues

Forecasted product revenues

Market opportunity

Competition

Partnerships and alliances

Fluidigm's SWOT analysis

IP Position

Appendix



For more information visit http://www.researchandmarkets.com/research/kbtd6q/fluidigm_due

Research and Markets
Laura Wood , Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +1-353-1-481-1716
Sector: Company Reports


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Accordant Health Services, a CVS Caremark Company, Receives URAC Case Management Accreditation
2. Endo Health Solutions to Present at the Cowen and Company 33rd Annual Health Care Conference
3. Auxilium Pharmaceuticals, Inc. to Present at the Cowen and Company 33rd Annual Healthcare Conference
4. Nektar Therapeutics to Present at the 33rd Annual Cowen and Company Healthcare Conference in Boston
5. Amgen To Present At The Cowen and Company 33rd Annual Health Care Conference
6. Omeros to Present at the Cowen and Company 33rd Annual Health Care Conference
7. PrimerLife.com, a Skolkovo Participant Company, Celebrates Anniversary of DNA Discovery with Launch of New Social Network
8. Collegium Pharmaceuticals CEO to Present at the Cowen & Company 33rd Annual Health Care Conference in Boston on March 6, 2013
9. Vanda Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care Conference
10. Sangamo BioSciences Announces Presentation At 33rd Annual Cowen And Company Health Care Conference
11. Neurocrine Biosciences To Present At The Cowen And Company 33rd Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... N.Y. , May 22, 2017  Lilac ... treatment Gene-Eden-VIR/Novirin, announces the launch of a ... English, the results of a clinical study that ... year treatment with Gene-Eden-VIR/Novirin in individuals suffering from ... to note that there are no other treatments ...
(Date:5/18/2017)...  Two Bayer U.S. Pharmaceutical leaders received top awards ... 28 th Woman of the Year ... longstanding mission of furthering the advancement and impact of ... Cindy Powell-Steffen , senior director of brand activation and ... Libby Howe , a regional business manager for New ...
(Date:5/15/2017)...  Amy Baxter MD, chief executive officer and founder ... relief, was awarded a 2017 Top 40 Healthcare Transformer ... at the MM&M Top 40 Healthcare Transformers dinner and ... on May 10, 2017. The dinner followed a full-day ... the pill."  "Innovation goes beyond invention," noted ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... June 23, 2017 , ... Moore Insurance, an eastern Texas ... to asset protection and financial planning services, is teaming up with the For ... of children with cancer and other chronic diseases. , The For A Day ...
(Date:6/22/2017)... ... 22, 2017 , ... United Benefit Advisors (UBA), the nation’s ... as its newest Partner Firm. Headquartered in Coconut Creek, Florida, Whipple & Company ... optimized benefit packages that strengthen the relationship between employer and employee. , “We ...
(Date:6/22/2017)... ... June 23, 2017 , ... Despite its pervasiveness, many ... reviews available that integrate basic science with clinical practice. Now, however, a timely review ... providing clinicians with insight into the etiology of NeuP and educating preclinical scientists on ...
(Date:6/22/2017)... ... June 22, 2017 , ... A June 12 article in ... about an apparent lack of oral hygiene by an aged parent who had recently ... matters, suggests a number of steps, including scheduling a dentist visit. Northridge Dental Works, ...
(Date:6/20/2017)... ... June 20, 2017 , ... Connance, a leading provider ... present how predictive analytics drive reimbursement optimization, with a focus on denial management ... , “The traditional approach to denied and underpaid claims leaves money on ...
Breaking Medicine News(10 mins):